Rittenhouse Hematology/Oncology

Philadelphia, Pennsylvania 19146

1 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, HER2-positive Advanced Solid Tumor

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer — Completed